LeMaitre Vascular, Inc.

NasdaqGM:LMAT Stok Raporu

Piyasa değeri: US$2.0b

LeMaitre Vascular Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 5/6

LeMaitre Vascular yıllık ortalama 13.3% oranında kazançlarını artırırken, Medical Equipment sektöründe kazançlar growing at 12.3% annual. Gelirler growing yılda ortalama 12.5% oranında artmaktadır. LeMaitre Vascular'in özkaynak karlılığı 12.5% ve net marjı 19.4%'dir.

Anahtar bilgiler

13.3%

Kazanç büyüme oranı

10.4%

EPS büyüme oranı

Medical Equipment Sektör Büyümesi8.9%
Gelir büyüme oranı12.5%
Özkaynak getirisi12.5%
Net Marj19.4%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Potentially Undervalued?

Oct 08
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Potentially Undervalued?

Investors Met With Slowing Returns on Capital At LeMaitre Vascular (NASDAQ:LMAT)

Sep 17
Investors Met With Slowing Returns on Capital At LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Price In Tune With Earnings

Sep 04
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Price In Tune With Earnings

If EPS Growth Is Important To You, LeMaitre Vascular (NASDAQ:LMAT) Presents An Opportunity

Aug 22
If EPS Growth Is Important To You, LeMaitre Vascular (NASDAQ:LMAT) Presents An Opportunity

LeMaitre Vascular: A Small Cap With Best-In-Industry Growth

Jul 23

Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$85.0 Based On Its Intrinsic Value?

Jul 12
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$85.0 Based On Its Intrinsic Value?

Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)?

Jun 18
Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)?

Return Trends At LeMaitre Vascular (NASDAQ:LMAT) Aren't Appealing

Jun 05
Return Trends At LeMaitre Vascular (NASDAQ:LMAT) Aren't Appealing

LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear

May 02
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear

Is Now The Time To Put LeMaitre Vascular (NASDAQ:LMAT) On Your Watchlist?

Apr 04
Is Now The Time To Put LeMaitre Vascular (NASDAQ:LMAT) On Your Watchlist?

Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Feb 29
Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?

Jan 19
What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?

Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Paint A Concerning Picture

Oct 27
Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Paint A Concerning Picture

Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?

Oct 11
Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?

Does LeMaitre Vascular (NASDAQ:LMAT) Deserve A Spot On Your Watchlist?

Aug 30
Does LeMaitre Vascular (NASDAQ:LMAT) Deserve A Spot On Your Watchlist?

The Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Don't Inspire Confidence

Jul 06
The Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Don't Inspire Confidence

Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$62.3 Based On Its Intrinsic Value?

May 20
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$62.3 Based On Its Intrinsic Value?

Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?

Mar 12
Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?

Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?

Oct 23
Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?

Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Oct 05
Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

LeMaitre Vascular (NASDAQ:LMAT) Could Be Struggling To Allocate Capital

Sep 13
LeMaitre Vascular (NASDAQ:LMAT) Could Be Struggling To Allocate Capital

LeMaitre Vascular: Reiterate Buy Thesis Following Strong Q2 Numbers

Sep 08

LeMaitre Vascular goes ex dividend tomorrow

Aug 23

Gelir ve Gider Dağılımı

LeMaitre Vascular nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NasdaqGM:LMAT Gelir, gider ve kazançlar (USD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 24213418016
30 Jun 24206387717
31 Mar 24200347517
31 Dec 23193307317
30 Sep 23186277016
30 Jun 23177256815
31 Mar 23169216514
31 Dec 22162216213
30 Sep 22160216013
30 Jun 22160225813
31 Mar 22158275512
31 Dec 21154275312
30 Sep 21152285111
30 Jun 21151294910
31 Mar 21135244610
31 Dec 20129214610
30 Sep 20122194710
30 Jun 20115164810
31 Mar 20119185010
31 Dec 1911718499
30 Sep 1911519489
30 Jun 1911118479
31 Mar 1910823469
31 Dec 1810623458
30 Sep 1810321447
30 Jun 1810422447
31 Mar 1810318437
31 Dec 1710117437
30 Sep 179815437
30 Jun 179614436
31 Mar 179312426
31 Dec 168911406
30 Sep 168611396
30 Jun 16829386
31 Mar 16799376
31 Dec 15788375
30 Sep 15767365
30 Jun 15746365
31 Mar 15735364
31 Dec 14704365
30 Sep 14703365
30 Jun 14673365
31 Mar 14652365
31 Dec 13643355

Kaliteli Kazançlar: LMAT yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: LMAT 'nin mevcut net kar marjları (19.4%) geçen yılın (14.7%) sinden daha yüksektir.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: LMAT şirketinin kazancı son 5 yılda yılda 13.3% oranında arttı.

Büyüme Hızlandırma: LMAT 'un son bir yıldaki kazanç büyümesi ( 51.5% ) 5 yıllık ortalamasını (yıllık 13.3% ) aşıyor.

Kazançlar vs. Sektör: LMAT geçen yılki kazanç büyümesi ( 51.5% ) Medical Equipment sektörünün 11.5% değerini aştı.


Özkaynak Getirisi

Yüksek ROE: LMAT 'nin Özsermaye Getirisi ( 12.5% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin